Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories

Friday, November 30, 2018

Athenex Inc a global biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies for the treatment of cancer and related conditions today announced that it has entered into an agreement with PharmaEssenti...

ALS Organizations Collaborate to Advance New Therapeutic into Trials

Friday, November 30, 2018

Several ALS organizations announced on Wednesday that the first participant was successfully given a dose of AT in the first inhuman trial of the potential treatment for ALS AT was developed by the ALS Therapy Development Institute ALS TDI with suppo...

WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies

Thursday, November 29, 2018

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and ABL Bio Corporation ABL Bio a privatelyheld South Korean biotechnology company deve...

FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder

Thursday, November 29, 2018

The US Food and Drug Administration today approved Firdapse amifampridine tablets for the treatment of LambertEaton myasthenic syndrome LEMS in adults LEMS is a rare autoimmune disorder that affects the connection between nerves and muscles and cause...

Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

Wednesday, November 28, 2018

Precision BioSciences and Servier today announced that the US Food and Drug Administration FDA has accepted the Investigational New Drug IND application for PBCAR an allogeneic antiCD CAR T therapy for Bcell acute lymphoblastic leukemia BALL and nonH...

Sygnature Discovery Establishes US Office in Cambridge, MA

Wednesday, November 28, 2018

Sygnature Discovery a leading independent integrated drug discovery and preclinical services company is continuing the expansion of its operations with the opening of its first US office located in Harvard Square Cambridge MassachusettsSince its...

Accenture Expands Platform for Drug Discovery and Innovation with Creation of Life Sciences Partner Ecosystem

Tuesday, November 27, 2018

Accenture has created an open partner ecosystem designed to help independent software vendors ISVs and life sciences companies team more effectively to accelerate drug discovery efforts and ultimately improve patient outcomesThe ecosystem is an i...

REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector

Tuesday, November 27, 2018

REGENXBIO Inc a leading clinicalstage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform and Rocket Pharmaceuticals Inc a leading USbased multiplatform gene t...

Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104

Monday, November 26, 2018

Immune Regulation Ltd a biopharmaceutical company developing first in class immuneresetting therapies for asthma and other inflammatory diseases announces positive results from a Phase study of its lead compound PIN Study C was a First Time in H...

Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the 60th American Society of Hematology Annual Meeting

Thursday, November 22, 2018

Selvita a clinical stage drug discovery and development company engaged in the research and development of novel cancer therapies today announced that preclinical data from SEL a CDK inhibitor in development for the treatment of acute myeloid leukemi...